December 16, 2016 / 9:42 AM / 7 months ago

BRIEF-Almirall receives $30 million in milestone payment from Astrazeneca

1 Min Read

Dec 16 (Reuters) - Almirall SA :

* Receives $30 million in milestone payment from Astrazeneca

* Phase III clinical trials in United States for combination of aclidinium and formoterol are progressing in line with expectations

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below